DiabetesSeriesLive

CME Presentations

Joslin Diabetes Grand Rounds - Dyslipidemia and Diabetes


Presentations

  • CME
    1.0

    Dyslipidemia and Diabetes: Evolving Guidelines, Treatments, Goals

    Speakers:Michael Rocco, MD, Medical Director of Stress Testing and Cardiac Rehabilitation
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Om P. Ganda, MD, Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee

    Duration: 60 minutes

    Presented on: March 29, 2017


Speakers


CME Information

Dyslipidemia and Diabetes: Evolving Guidelines, Treatments, Goals

Jointly provided by Primary Care Network and PlatformQ Health Education, LLC

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Online Activity Primary Care Network designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Online On-Demand Enduring Material Primary Care Network designates each enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals will be issued a certificate of participation.

Primary Care Network has been awarded Accreditation with Commendation (2013-2019) by the Accreditation Council for Continuing Medical Education (ACCME).

DATE OF RELEASE/EXPIRATION Live Online Activity Wednesday March 29, 2017 from 12:00 – 1:00PM EDT.

Enduring Material The enduring material will be available from March 29, 2017 – September 29, 2017.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Implement key elements and majorchanges in the updated treatment guidelines for dyslipidemia with a focus on how they would apply to treatment design for dyslipidemia and diabetes
Identify when newer non-statin drug therapies may be indicated for patients with high lipid-related CVD risk despite maximum tolerated statin therapy
Delineate the pharmacology, approved indications, and potential barriers to overcome ineffective use of PCSK9 inhibitors in patients at high risk for CVD events
 

TARGET AUDIENCE This activity is intended for primary care clinicians and other health care providers, such as cardiologists and nephrologists, who provide frontline glycemic management for type 2 diabetes and related conditions, as well as clinically–focused diabetologists and endocrinologists; diabetes educators, and other non-MD health care providers involved in the diagnosis, treatment, education, and management of patients with T2DM, including other medical practice support staff who interact with people who have diabetes (RNs, LPNs, medical office assistants).

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT This activity is supported by an educational funding donation provided by Amgen.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To participate in the activity, go to http://www.diabetesserieslive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the pre and post-test and activity evaluation. Participants must receive a minimum score of 70% on the post-test in order to receive a certificate.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

STATEMENT OF DISCLOSURE AND INDEPENDENCE It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are planned, developed, and conducted in accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN's Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are considered Planning Committee Members. Planning Committee Members include individuals involved in a CME activity who may develop, edit, review and/or present content. Planning Committee Members are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Relevant Financial Relationship:
Richard Beaser, MD None
Om P. Ganda, MD Medical Lectures: Merck & Co. Advisory Board: Novo Nordisk, Sanofi–Aventis Research/Grants Amarin
Michael Rocco, MD None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Relevant Financial Relationship
Brian Koffman, MDCM, DCFP, DABFM, MS Ed Primary Care Network CME Content Reviewer Advisory Board & Speaker's Bureau: Ironwood Pharmaceuticals Patient Speaker: Juno Therapeutics, Verastem
 

The following PCN planner and manager, Jill Hays, hereby state that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable): This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.

CONTACT INFORMATION Accreditation Support: Please contact Primary Care Network at http://www.primarycarenetwork.org/.

Technical Support: For any technical issues or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at http://www.diabetesserieslive.com/